BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
- Theranostics 2016
- 6:2
--Medical Technology--Medtech
--Medical Technology--Medtech